OKYO Pharma Limited, (OKYO): Price and Financial Metrics
OKYO Price/Volume Stats
| Current price | $1.06 | 52-week high | $1.96 |
| Prev. close | $1.09 | 52-week low | $0.81 |
| Day low | $1.04 | Volume | 30,500 |
| Day high | $1.09 | Avg. volume | 116,400 |
| 50-day MA | $1.08 | Dividend yield | N/A |
| 200-day MA | $1.23 | Market Cap | 35.87M |
OKYO Stock Price Chart Interactive Chart >
OKYO Pharma Limited, (OKYO) Company Bio
OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. It is developing OK-101 for the treatment of dry eye disease; and OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain. The company is also developing chemerin and chemerin analogues to treat the cytokine release syndrome associated with COVID-19 infections and other conditions, such as acute respiratory distress syndrome. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.
OKYO Price Returns
| 1-mo | -0.93% |
| 3-mo | 4.95% |
| 6-mo | -12.40% |
| 1-year | -40.45% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -40.11% |
| 2023 | -7.33% |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...